BURLINGTON, ON, Feb. 19,
2025 /CNW/ - EcoSynthetix Inc. (TSX: ECO)
("EcoSynthetix" or the "Company"), a renewable
chemicals company that produces a portfolio of commercially proven
bio-based products, today announced its financial and operational
results for the three months (Q4 2024) and twelve months (FY 2024)
ended December 31, 2024. Financial
references are in U.S. dollars unless otherwise indicated.
Highlights
(Comparison periods in each case are the three months and
twelve months ended December 31,
2023, respectively)
- Recorded net sales of $5.4
million, up 91%, and $18.5
million, up 46%, compared to the prior periods,
respectively, enabled by 82% and 56% higher volumes from increased
demand.
- Recorded an Adjusted EBITDA1 of $0.1 million and $(0.9)
million, an improvement of $1.1
million and $1.7 million from
the prior periods, respectively.
- Won a new commercial line using the Company's SurfLock™
strength aids with a leading international pulp manufacturer,
subsequent to the end of the quarter.
- Experienced increased demand across all end markets from higher
usage at commercial mills, including the highest quarterly volumes
used to date by the particleboard producer backward integrated
into an international retailer.
- EcoSynthetix was climate positive in 2024, enabled by higher
usage of its low carbon products by customers which led to avoiding
100% of the carbon emissions associated with the business.
- Purchased and cancelled 174,000 and 678,500 common shares in Q4
2024 and FY 2024, respectively, under the normal course issuer
bid for total consideration of $0.5
million and $2.2
million.
- Maintained a strong balance sheet with cash and term deposits
of $32.2 million as at December 31, 2024.
"We continue to see strong demand across all end markets which
drove higher volumes and nearly doubled sales over a soft
comparable period in 2023," said Jeff
MacDonald, CEO of EcoSynthetix. "We continue to make
progress with a leading international pulp manufacturer with their
first line moving to commercial operations using our SurfLock™
strength aids. The pulp end market represents a significant growth
opportunity as it relates to volumes and the value contributed by
SurfLock™ to the finished product. Volumes were also up during the
quarter with the particleboard manufacturer that is backward
integrated with an international retailer. We are seeing
consistently higher usage from earlier periods of our wood
composites binder, DuraBind™, with this account. The momentum
across these two key end markets, as well as Dow expanding the
applications using our all-natural personal care ingredient, sets
the stage for stronger growth. Industrial-scale change is always
challenging but our binders are increasingly becoming a core
ingredient to these manufacturers. With this progress across our
most important strategic opportunities the business enters 2025 in
a strong position from which to grow."
Financial Summary
Net Sales
Net sales were $5.4 million and
$18.5 million for Q4 2024 and FY
2024, respectively, compared to $2.8
million and $12.7 million for
the corresponding periods in 2023. The 91% increase in the
quarterly period was due to higher volumes, which increased sales
$2.3 million, or 82%, and a higher
average selling price which increased sales $0.3 million or 9%. The higher volumes were
primarily due to improved demand across all end markets and the
higher average selling price was primarily due to favourable
product mix. The 46% increase in the annual period was due to
higher volumes of $7.1 million, or
56%, partly offset by a lower average selling price of $1.2 million, or 9%. The higher volumes were
primarily due to improved demand across all end markets. The lower
average selling price was primarily due to lower manufacturing
costs which were partially passed on to customers, as well as
product mix.
Gross Profit
Gross profit was $1.6 million and
$5.3 million for Q4 2024 and FY 2024,
respectively, compared to $0.5
million and $2.8 million for
the corresponding periods in 2023. The increase in the quarterly
period was primarily due to higher volumes, a higher average
selling price and lower manufacturing costs. The increase in the
annual period was primarily due to higher volumes and lower
manufacturing costs and was partially offset by a lower average
selling price.
Gross profit as a percentage of sales was 28.9% and 28.6% for Q4
2024 and FY 2024, respectively, compared to 16.3% and 22.0% in the
corresponding periods in 2023. Gross profit as a percentage of
sales adjusted for manufacturing depreciation was 34.4% and 33.2%
for Q4 2024 and FY 2024, respectively, compared to 21.9% and 28.9%
for the corresponding periods in 2023. The increase in the
quarterly period for both metrics was primarily due to lower
manufacturing costs and a higher average selling price. The
increase in the annual period for each one was primarily due to
lower manufacturing costs partially offset by a lower average
selling price.
Selling, General and Administrative
Selling, general and administrative expenses (SG&A) were
$1.8 million and $6.5 million for Q4 2024 and FY 2024,
respectively, compared to $1.3
million and $5.0 million for
the corresponding periods in 2023. The change in the quarterly
period was primarily due to foreign exchange losses and higher
variable-based compensation and performance-based equity
compensation. The change in the annual period was primarily due to
increased variable-based compensation and performance-equity
compensation as well as asset relocation costs associated with the
Company's manufacturing footprint realignment project.
Research and Development
Research and development (R&D) costs were $0.4 million and $2.0
million for Q4 2024 and FY 2024, respectively, compared to
$0.6 million and $2.3 million in the corresponding periods in
2023. The decrease in both periods was primarily due to lower
labour and overhead costs allocated to R&D and lower product
scale-up expenses. R&D expense as a percentage of sales was 7%
and 11% for Q4 2024 and FY 2024, respectively, compared to 20% and
18% in the corresponding periods in 2023. The Company's R&D
efforts continue to focus on further enhancing value for our
existing products and expanding addressable opportunities.
Adjusted EBITDA1
Adjusted EBITDA was $0.1 million
for Q4 2024, a $1.1 million
improvement compared to an Adjusted EBITDA loss of $1.0 million in the same period in 2023. Adjusted
EBITDA loss was $0.9 million for FY
2024, a $1.7 million improvement
compared to $2.5 million in FY 2023.
The improvement in each period was due to higher gross profit
partially offset by higher operating expenses adjusted for non-cash
items.
Net Loss
Net loss was $0.2 million, or
$0.00 per common share, and
$1.4 million, or $0.02 per common share, for Q4 2024 and FY 2024,
respectively, compared to a net loss of $0.6
million, or $0.01 per common
share, and $2.8 million, or
$0.05 per common share, in the
corresponding periods in 2023. The improvement in the quarterly
period was primarily due to a $0.8
million lower loss from operations and $0.1 million in higher net interest income offset
by a $0.5 million gain on the
disposal of PP&E recognized in the prior period. The
improvement in the annual period was primarily due to a
$1.3 million lower loss from
operations, $0.5 million in higher
net interest income offset by a net change of $0.4 million relating to gains on the disposal of
PP&E. The higher net interest income during each period was due
to an increase in interest rates on cash and term deposits.
Liquidity
Cash on hand and term deposits were $32.2
million as at December 31,
2024, compared to $33.3
million as at December 31,
2023. The Company purchased and cancelled 174,000 and
678,500 common shares under the NCIB during Q4 2024 and FY 2024,
respectively, for consideration of $0.5
million and $2.2 million.
Notice of Conference Call
EcoSynthetix will host a conference call Thursday, February 20, at 8:30 am ET to discuss its financial results.
Jeff MacDonald, CEO, and
Robert Haire, CFO, will co-chair the
call. All interested parties can instantly join the call by phone,
by following the URL https://emportal.ink/40FnYWK to easily
register and be connected into the conference call automatically or
the conventional method by dialling (416) 945- 7677 or (888)
699-1199 with the conference identification of 88298#. Please dial
in 15 minutes prior to the call to secure a line. A live audio
webcast of the conference call will also be available at
www.ecosynthetix.com or https://app.webinar.net/ey7ZaY7Ew5X. The
presentation will be accompanied by slides, which will be available
via the webcast link and the Company's website. Please connect at
least 15 minutes prior to the conference call to ensure adequate
time for any software download that may be required to join the
webcast.
1Non-IFRS Financial Measures
This press release makes reference to certain non-IFRS measures.
These non-IFRS measures are not recognized measures under IFRS, do
not have a standardized meaning prescribed by IFRS and are
therefore unlikely to be comparable to similar measures presented
by other companies. Rather, these measures are provided as
additional information to complement those IFRS measures by
providing a further understanding of results of operations of
EcoSynthetix from management's perspective. Accordingly, they
should not be considered in isolation nor as a substitute for
analysis of the financial information of EcoSynthetix reported
under IFRS. The Company uses non-IFRS measures such as Adjusted
EBITDA to provide investors with a supplemental measure of
operating performance and thus highlight trends in its core
business that may not otherwise be apparent when relying solely on
IFRS financial measures. Management also believes that securities
analysts, investors and other interested parties frequently use
non-IFRS measures in the evaluation of issuers. Management also
uses non-IFRS measures in order to facilitate operating performance
comparisons from period to period, prepare annual operating budgets
and assess the Company's ability to meet its capital expenditure
and working capital requirements.
Adjusted EBITDA is not a measure recognized under IFRS and does
not have a standardized meaning prescribed by IFRS. See "IFRS and
Non-IFRS Measures." The Company presents Adjusted EBITDA because
the Company believes it facilitates investors' use of operating
performance comparisons from period to period and company to
company by backing out potential differences caused by variations
in capital structures (affecting relative interest expense), the
book amortization of intangibles (affecting relative amortization
expense) and the age and book value of property and equipment
(affecting relative depreciation expense). The Company also
presents Adjusted EBITDA because it believes it is frequently used
by securities analysts, investors and other interested parties as a
measure of financial performance. Adjusted EBITDA as presented
herein are not recognized measures under IFRS and should not be
considered as an alternative to operating income or net income as
measures of operating results or an alternative to cash flows as
measures of liquidity. Adjusted EBITDA is defined as consolidated
net income (loss) before net interest expense, income taxes,
depreciation, amortization, gain or loss on disposals of property,
plant and equipment and other non-cash expenses and charges
deducted in determining consolidated net income (loss).
The following table reconciles net loss to Adjusted EBITDA loss
for the three months and twelve months ended December 31, 2024, and December 31, 2023:
|
Three months
ended
December 31, 2024
|
Three months
ended
December 31, 2023
|
Twelve months
ended
December 31, 2024
|
Twelve months
ended
December 31, 2023
|
Net loss
|
(206,884)
|
(584,624)
|
(1,366,926)
|
(2,821,047)
|
Depreciation
|
352,162
|
247,690
|
1,164,739
|
1,268,985
|
Share-based
compensation
|
362,440
|
224,579
|
1,158,583
|
715,887
|
Gain on disposal of
property, plant and equipment
|
-
|
(511,038)
|
(90,000)
|
(511,038)
|
Interest
income
|
(415,377)
|
(345,699)
|
(1,724,441)
|
(1,175,590)
|
Adjusted EBITDA
(loss)
|
92,341
|
(969,092)
|
(858,045)
|
(2,522,803)
|
About EcoSynthetix Inc. (www.ecosynthetix.com)
EcoSynthetix offers a range of sustainable engineered
biopolymers that allow customers to reduce their use of harmful
materials, such as formaldehyde and styrene-based chemicals. The
Company's flagship products, DuraBind™, Surflock™, Bioform™, and
EcoSphere®, are used to manufacture wood composites, personal care,
paper, tissue and packaging products, and enable performance
improvements, economic benefits and carbon footprint reduction. The
Company is publicly traded on the Toronto Stock Exchange
(T:ECO).
Forward-Looking Statements
Certain statements in this Press Release constitute
"forward-looking" statements that involve known and unknown risks,
uncertainties and other factors which may cause the actual results,
performance, objectives or achievements of the Company, or industry
results, to be materially different from any future results,
performance, objectives or achievements expressed or implied by
such forward looking statements. The forward-looking statements in
this Press Release include, but are not limited to, statements
regarding the Company's plans to execute its commercial strategy,
deliver meaningful growth across all three product categories,
convert high-value strategic prospects into customers, and other
statements regarding the Company's plans and expectations in 2025.
These statements reflect our current views regarding future events
and operating performance and are based on information currently
available to us, and speak only as of the date of this Press
Release. These forward-looking statements involve a number of
risks, uncertainties and assumptions and should not be read as
guarantees of future performance or results, and will not
necessarily be accurate indications of whether or not such
performance or results will be achieved. Those assumptions and
risks include, but are not limited to, the Company's ability to
successfully allocate capital as needed and to develop new
products, as well as the fact that our results of operations and
business outlook are subject to significant risk, volatility and
uncertainty. Many factors could cause our actual results,
performance or achievements to be materially different from any
future results, performance or achievements that may be expressed
or implied by such forward-looking statements, including the
factors identified in the "Risk Factors" section of the Company's
Annual Information Form dated February 18,
2025. Should one or more of these risks or uncertainties
materialize, or should assumptions underlying the forward-looking
statements prove incorrect, actual results may vary materially from
those described in this Press Release as intended, planned,
anticipated, believed, estimated or expected. Unless required by
applicable securities law, we do not intend and do not assume any
obligation to update these forward-looking statements.
EcoSynthetix
Inc.
|
|
|
Consolidated Balance
Sheets
|
|
|
(expressed in US
dollars)
|
|
|
|
|
|
|
|
|
|
December 31,
2024
|
Decemebr 31,
2023
|
Assets
|
|
|
|
|
|
Current
assets
|
|
|
Cash
|
7,721,403
|
4,915,445
|
Term
deposits
|
24,473,985
|
28,366,765
|
Accounts
receivable
|
2,325,369
|
1,549,443
|
Inventory
|
2,828,748
|
3,642,923
|
Prepaid
expenses
|
90,306
|
91,917
|
|
37,439,811
|
38,566,493
|
|
|
|
Non-current
assets
|
|
|
Property, plant and
equipment
|
3,845,010
|
4,268,820
|
|
|
|
|
|
|
Total
assets
|
41,284,821
|
42,835,313
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
Current
liabilities
|
|
|
Trade accounts payables
and accrued liabilities
|
1,938,831
|
1,607,140
|
|
|
|
Non-current
liabilities
|
|
|
Lease
liability
|
-
|
258,278
|
|
|
|
Total
liabilities
|
1,938,831
|
1,865,418
|
Shareholders'
Equity
|
|
|
Common
shares
|
489,246,909
|
490,263,781
|
Contributed
surplus
|
11,013,304
|
10,253,411
|
Accumulated
deficit
|
(460,914,223)
|
(459,547,297)
|
Total shareholders'
equity
|
39,345,990
|
40,969,895
|
|
|
|
Total liabilities
and shareholders' equity
|
41,284,821
|
42,835,313
|
EcoSynthetix
Inc.
|
|
|
|
|
|
Consolidated
Statements of Operations and Comprehensive Loss
|
|
|
|
For the three and
twelve months ended December 31, 2024 and December 31,
2023
|
|
|
|
|
(expressed in US
dollars)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended December 31,
|
|
Twelve months
ended December 31,
|
|
2024
|
2023
|
|
2024
|
2023
|
|
|
|
|
|
|
Net
sales
|
5,432,916
|
2,843,437
|
|
18,536,670
|
12,659,623
|
|
|
|
|
|
|
Cost of
sales
|
3,861,435
|
2,379,389
|
|
13,229,567
|
9,877,792
|
|
|
|
|
|
|
Gross profit on
sales
|
1,571,481
|
464,048
|
|
5,307,103
|
2,781,831
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
Selling, general and
administrative
|
1,836,858
|
1,347,909
|
|
6,479,298
|
4,986,580
|
Research and
development
|
356,884
|
557,500
|
|
2,009,172
|
2,302,926
|
|
2,193,742
|
1,905,409
|
|
8,488,470
|
7,289,506
|
|
|
|
|
|
|
Loss from
operations
|
(622,261)
|
(1,441,361)
|
|
(3,181,367)
|
(4,507,675)
|
|
|
|
|
|
|
Net interest
income
|
415,377
|
345,699
|
|
1,724,441
|
1,175,590
|
Gain on disposal of
property, plant and equipment
|
-
|
511,038
|
|
90,000
|
511,038
|
|
415,377
|
856,737
|
|
1,814,441
|
1,686,628
|
Net loss and
comprehensive loss
|
(206,884)
|
(584,624)
|
|
(1,366,926)
|
(2,821,047)
|
|
|
|
|
|
|
Basic and diluted
loss per common share
|
(0.00)
|
(0.01)
|
|
(0.02)
|
(0.05)
|
Weighted average
number of common shares outstanding
|
58,593,194
|
58,635,640
|
|
58,667,534
|
58,926,302
|
EcoSynthetix
Inc.
|
|
|
|
|
|
Consolidated
Statements of Cash Flows
|
|
|
|
|
|
For the three and
twelve months ended December 31, 2024 and December 31,
2023
|
|
|
|
|
(expressed in US
dollars)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended December 31,
|
|
Twelve months
ended December 31,
|
|
2024
|
2023
|
|
2024
|
2023
|
Cash provided by
(used in)
|
|
|
|
|
|
|
|
|
|
|
|
Operating
activities
|
|
|
|
|
|
Net loss and
comprehensive loss
|
(206,884)
|
(584,624)
|
|
(1,366,926)
|
(2,821,047)
|
Items not affecting
cash
|
|
|
|
|
|
Depreciation
|
352,162
|
247,690
|
|
1,164,739
|
1,268,985
|
Share-based
compensation
|
362,440
|
224,579
|
|
1,158,583
|
715,887
|
Other
|
32,383
|
(107,101)
|
|
8,015
|
(78,581)
|
Gain on disposal of
property, plant and equipment
|
-
|
(511,038)
|
|
(90,000)
|
(511,038)
|
Changes in non-cash
working capital
|
|
|
|
|
|
Accounts
receivable
|
(77,875)
|
(5,504)
|
|
(775,926)
|
1,380,943
|
Inventory
|
(524,005)
|
398,662
|
|
825,269
|
1,669,733
|
Prepaid expenses
|
70,045
|
75,022
|
|
1,611
|
(6,786)
|
Trade accounts payables and
accrued liabilities
|
(561,452)
|
(409,241)
|
|
536,415
|
(1,048,296)
|
Interest on term
deposits
|
|
|
|
|
|
Interest received on term deposits
|
49,007
|
-
|
1,223,981
|
743,536
|
Accrued interest on term deposits
|
(375,685)
|
(304,845)
|
|
(1,581,201)
|
(996,347)
|
|
(879,864)
|
(976,400)
|
|
1,104,560
|
316,989
|
|
|
|
|
|
|
Investing
activities
|
|
|
|
|
|
Purchase of property,
plant and equipment
|
(154,514)
|
(950,024)
|
|
(868,453)
|
(1,626,468)
|
Proceeds on disposal of
property, plant and equipment
|
-
|
511,038
|
|
90,000
|
511,038
|
Receipts on mature term
deposits
|
3,750,000
|
-
|
|
31,550,000
|
27,093,884
|
Purchase of term
deposits
|
-
|
-
|
|
(27,300,000)
|
(23,982,840)
|
|
3,595,486
|
(438,986)
|
|
3,471,547
|
1,995,614
|
|
|
|
|
|
|
Financing
activities
|
|
|
|
|
|
Payments made on lease
liability
|
(78,597)
|
(73,402)
|
|
(317,106)
|
(287,921)
|
Common shares
repurchased
|
(514,426)
|
(734,131)
|
|
(2,175,924)
|
(2,411,337)
|
Exercise of common
share options
|
49,903
|
404,260
|
|
760,362
|
431,127
|
|
(543,120)
|
(403,273)
|
|
(1,732,668)
|
(2,268,131)
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate
changes on cash
|
(50,974)
|
119,032
|
|
(37,481)
|
62,367
|
|
|
|
|
|
|
Change in cash
during the period
|
2,121,528
|
(1,699,627)
|
|
2,805,958
|
106,839
|
|
|
|
|
|
|
Cash - Beginning of
period
|
5,599,875
|
6,615,072
|
|
4,915,445
|
4,808,606
|
|
|
|
|
|
|
Cash - End of
period
|
7,721,403
|
4,915,445
|
|
7,721,403
|
4,915,445
|
SOURCE EcoSynthetix Inc.